Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03726944 · ClinicalTrials.gov registry record · NA
The Feasibility of Delivering Consumer-based Meditation Applications to Myeloproliferative Neoplasm Patients
A NA study, sponsored by Arizona State University.
- Completed
- Registry status
- NA
- Development phase
- 128
- Enrollment target
NCT03726944 is a NA study that has completed, run by Arizona State University. The registered enrollment target is 128 participants.
The verdict
NCT03726944, a NA study, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
Study Summary
This study was a four-group randomized pilot trial in myeloproliferative neoplasm (MPN) patients. Patients were recruited nationally through organizational partners and social media. Eligible and consented patients were enrolled into one of four groups, two of which received varying orders of two consumer-based apps (unnamed consumer-based \[CB\] app and Calm App) and two that received one of the apps alone for the second four weeks of the eight week intervention after an educational control condition. Participants were asked to perform 10 min/day of smartphone-based meditation irrespective of the app and/or the order in which they received the apps. Feasibility outcomes were measured at week five and nine with an online survey. Feasibility outcomes were acceptability, demand, and limited efficacy for depression, anxiety, pain intensity, sleep disturbance, sexual function, quality of life, global health, and total symptom burden. The purpose of this study was to examine the feasibility of the use of two different consumer-based meditation smartphone applications (i.e., apps) in MPN patients. Specific aim #1: Examine the feasibility of daily meditation delivered using a consumer-based mobile app. Hypothesis: It will feasible to deliver smartphone-based meditation to MPN patients. Exploratory Aim: Explore the preliminary effects of daily meditation delivered using a consumer-based mobile app on MPN self-report fatigue, anxiety, depression, pain intensity, sleep disturbance, sexual function, global health, quality of life, and total symptom burden. Hypothesis: There will be demonstrated preliminary effects on patient-reported outcomes in MPN patients.
Interventions
- OTHER Educational Control
- BEHAVIORAL Calm App Meditation
- BEHAVIORAL Unnamed Consumer-Based App Meditation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2017-07-31 |
| Est. Completion | 2018-04-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03726944
The ClinicalTrials.gov registry entry for NCT03726944 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arizona State University, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Educational Control is the first listed.
NCT03726944 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03726944 about?
NCT03726944 is a clinical study titled "The Feasibility of Delivering Consumer-based Meditation Applications to Myeloproliferative Neoplasm Patients". This study was a four-group randomized pilot trial in myeloproliferative neoplasm (MPN) patients. Patients were recruited nationally through organizational partners and social media. Eligible and consented patients were enrolled into one of four groups, two of which received varying orders of two co...
What is the current status of trial NCT03726944?
This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2017-07-31. Estimated completion is 2018-04-02.
What interventions are being tested in trial NCT03726944?
The interventions under investigation include: Educational Control (OTHER), Calm App Meditation (BEHAVIORAL), Unnamed Consumer-Based App Meditation (BEHAVIORAL).
Who is sponsoring clinical trial NCT03726944?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.